The shared genetic landscape of blood cell traits and risk of neurological and psychiatric disorders

[1]  Michael F. Green,et al.  Mapping genomic loci implicates genes and synaptic biology in schizophrenia , 2022, Nature.

[2]  Jonathan P. Beauchamp,et al.  Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals , 2022, Nature Genetics.

[3]  G. Davey Smith,et al.  Educational attainment as a modifier for the effect of polygenic scores for cardiovascular risk factors: cross-sectional and prospective analysis of UK Biobank , 2021, medRxiv.

[4]  T. Ge,et al.  Use of the PsycheMERGE Network to Investigate the Association Between Depression Polygenic Scores and White Blood Cell Count , 2021, JAMA psychiatry.

[5]  M. Beutel,et al.  Smoking and Neuropsychiatric Disease—Associations and Underlying Mechanisms , 2021, International journal of molecular sciences.

[6]  Melissa J. Green,et al.  Genetic estimates of correlation and causality between blood-based biomarkers and psychiatric disorders , 2021, medRxiv.

[7]  Andrew D. Johnson,et al.  Transcriptional profile of platelets and iPSC-derived megakaryocytes from whole genome and RNA sequencing. , 2020, Blood.

[8]  F. Gianfagna,et al.  Assessing Genetic Overlap Between Platelet Parameters and Neurodegenerative Disorders , 2020, Frontiers in Immunology.

[9]  T. Münte,et al.  Platelets as Mediators of Neuroinflammation and Thrombosis , 2020, Frontiers in Immunology.

[10]  E. Tolosa,et al.  Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance , 2020, Movement disorders : official journal of the Movement Disorder Society.

[11]  Y. Pawitan,et al.  High-definition likelihood inference of genetic correlations across human complex traits , 2020, Nature Genetics.

[12]  T. Walker,et al.  Platelets in Neurodegenerative Conditions—Friend or Foe? , 2020, Frontiers in Immunology.

[13]  Katherine M. Siewert,et al.  Cross-trait analyses with migraine reveal widespread pleiotropy and suggest a vascular component to migraine headache , 2020, International journal of epidemiology.

[14]  Daowen Wang,et al.  Integrated Analysis of Summary Statistics to Identify Pleiotropic Genes and Pathways for the Comorbidity of Schizophrenia and Cardiometabolic Disease , 2020, Frontiers in Psychiatry.

[15]  P. Visscher,et al.  Conditional GWAS analysis to identify disorder-specific SNPs for psychiatric disorders , 2020, Molecular Psychiatry.

[16]  William J. Astle,et al.  The Polygenic and Monogenic Basis of Blood Traits and Diseases , 2020, Cell.

[17]  W. Yue,et al.  Integration analysis of methylation quantitative trait loci and GWAS identify three schizophrenia risk variants , 2020, Neuropsychopharmacology.

[18]  Runan Yao,et al.  ShinyGO: a graphical gene-set enrichment tool for animals and plants , 2019, Bioinform..

[19]  J. Kleinman,et al.  NURR1 and ERR1 Modulate the Expression of Genes of a DRD2 Coexpression Network Enriched for Schizophrenia Risk , 2019, The Journal of Neuroscience.

[20]  Sonja W. Scholz,et al.  Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies , 2019, The Lancet Neurology.

[21]  I. Deary,et al.  Genome-wide analysis identifies molecular systems and 149 genetic loci associated with income , 2019, Nature Communications.

[22]  Matthew C. Sims,et al.  The role of haematological traits in risk of ischaemic stroke and its subtypes , 2019, Brain : a journal of neurology.

[23]  Stephanie A. Santorico,et al.  Cross-disorder analysis of schizophrenia and 19 immune-mediated diseases identifies shared genetic risk , 2019, Human molecular genetics.

[24]  Simon C. Potter,et al.  Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility , 2019, Science.

[25]  Till F. M. Andlauer,et al.  The genetic relationship between educational attainment and cognitive performance in major psychiatric disorders , 2019, Translational Psychiatry.

[26]  P. Maeder,et al.  Associated Factors and Long-Term Prognosis of 24-Hour Worsening of Arterial Patency After Ischemic Stroke. , 2019, Stroke.

[27]  Joseph H. Marcus,et al.  Mendelian randomization accounting for correlated and uncorrelated pleiotropic effects using genome-wide summary statistics , 2019, bioRxiv.

[28]  H. ten Cate,et al.  Role of Platelet Glycoprotein VI and Tyrosine Kinase Syk in Thrombus Formation on Collagen-Like Surfaces , 2019, International journal of molecular sciences.

[29]  Robert Karlsson,et al.  RICOPILI: Rapid Imputation for COnsortias PIpeLIne , 2019, bioRxiv.

[30]  Alicia R. Martin,et al.  Identification of common genetic risk variants for autism spectrum disorder , 2019, Nature Genetics.

[31]  Naomi R. Wray,et al.  Improved polygenic prediction by Bayesian multiple regression on summary statistics , 2019, Nature Communications.

[32]  John P. Rice,et al.  Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use , 2018, Nature Genetics.

[33]  Timothy J. Hohman,et al.  Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk , 2019, Nature Genetics.

[34]  Dajiang J. Liu,et al.  Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use , 2018, Nature Genetics.

[35]  Sikandar Z. Khan,et al.  High plateletcrit is associated with early loss of patency after open and endovascular interventions for chronic limb ischemia. , 2018, Journal of vascular surgery.

[36]  Stephen R. Williams,et al.  Genome Analyses of >200,000 Individuals Identify 58 Loci for Chronic Inflammation and Highlight Pathways that Link Inflammation and Complex Disorders. , 2018, American journal of human genetics.

[37]  Sina A. Gharib,et al.  Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis , 2018, bioRxiv.

[38]  Simone Lista,et al.  Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic , 2018, Nature Reviews Neurology.

[39]  Alicia R. Martin,et al.  Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder , 2018, Nature Genetics.

[40]  M. Large,et al.  Meta‐analysis examining the epidemiology of clozapine‐associated neutropenia , 2018, Acta psychiatrica Scandinavica.

[41]  G. Davey Smith,et al.  Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians , 2018, British Medical Journal.

[42]  Sina A. Gharib,et al.  Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood , 2018, Nature Communications.

[43]  Timothy A. Miller,et al.  Genome-wide Analyses Identify KIF5A as a Novel ALS Gene in and for Therapeutic , 2018 .

[44]  Xiao-yan Li,et al.  The integrated landscape of causal genes and pathways in schizophrenia , 2018, Translational Psychiatry.

[45]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[46]  Sina A. Gharib,et al.  Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood , 2018, Nature Communications.

[47]  Warren W. Kretzschmar,et al.  Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression , 2017, Nature Genetics.

[48]  Andrew D. Johnson,et al.  Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes , 2018, Nature Genetics.

[49]  J. Freedman,et al.  Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis , 2018, Circulation research.

[50]  Robert M. Maier,et al.  Causal associations between risk factors and common diseases inferred from GWAS summary data , 2017, Nature Communications.

[51]  Bogdan Pasaniuc,et al.  Local genetic correlation gives insights into the shared genetic architecture of complex traits , 2016, bioRxiv.

[52]  A. Price,et al.  Distinguishing genetic correlation from causation across 52 diseases and complex traits , 2017, bioRxiv.

[53]  Ellis Patrick,et al.  An xQTL map integrates the genetic architecture of the human brain’s transcriptome and epigenome , 2017, Nature Neuroscience.

[54]  Melissa J. Green,et al.  Genome-wide association study identifies 30 Loci Associated with Bipolar Disorder , 2017, bioRxiv.

[55]  P. Visscher,et al.  Causal associations between risk factors and common diseases inferred from GWAS summary data , 2017, bioRxiv.

[56]  R. Marioni,et al.  Identification of 55,000 Replicated DNA Methylation QTL , 2017, Scientific Reports.

[57]  Fernando Pires Hartwig,et al.  Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption , 2017, bioRxiv.

[58]  S. Thompson,et al.  Interpreting findings from Mendelian randomization using the MR-Egger method , 2017, European Journal of Epidemiology.

[59]  Stephen Burgess,et al.  Sensitivity Analyses for Robust Causal Inference from Mendelian Randomization Analyses with Multiple Genetic Variants , 2016, Epidemiology.

[60]  E. Schadt,et al.  Large-Scale Identification of Common Trait and Disease Variants Affecting Gene Expression. , 2017, American journal of human genetics.

[61]  William J. Astle,et al.  Allelic Landscape of Human Blood Cell Trait Variation and Links , 2016 .

[62]  S. Thompson,et al.  Bias due to participant overlap in two‐sample Mendelian randomization , 2016, Genetic epidemiology.

[63]  Hammad Naveed,et al.  Lymphopenia in treatment-naive relapsing multiple sclerosis , 2016, Neurology: Neuroimmunology & Neuroinflammation.

[64]  D. Siskind,et al.  Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis , 2016, British Journal of Psychiatry.

[65]  N. Eriksson,et al.  Nature Genetics Advance Online Publication Meta-analysis of 375,000 Individuals Identifies 38 Susceptibility Loci for Migraine , 2022 .

[66]  Benjamin A. Logsdon,et al.  Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia , 2016, Nature Neuroscience.

[67]  G. Davey Smith,et al.  Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.

[68]  P. Visscher,et al.  Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets , 2016, Nature Genetics.

[69]  Chi-Yu Lai,et al.  Biomarkers in schizophrenia: A focus on blood based diagnostics and theranostics. , 2016, World journal of psychiatry.

[70]  R. Kahn,et al.  Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls. , 2016, Schizophrenia bulletin.

[71]  C. Spencer,et al.  A contribution of novel CNVs to schizophrenia from a genome-wide study of 41,321 subjects: CNV Analysis Group and the Schizophrenia Working Group of the Psychiatric Genomics Consortium , 2016, bioRxiv.

[72]  Daniel R Weinberger,et al.  Mapping DNA methylation across development, genotype, and schizophrenia in the human frontal cortex , 2015, Nature Neuroscience.

[73]  M. O’Donovan,et al.  Methylation quantitative trait loci in the developing brain and their enrichment in schizophrenia-associated genomic regions. , 2015 .

[74]  Jia-wei Zhou,et al.  Neuroinflammation in Parkinson’s disease and its potential as therapeutic target , 2015, Translational Neurodegeneration.

[75]  Joseph K. Pickrell,et al.  Approximately independent linkage disequilibrium blocks in human populations , 2015, bioRxiv.

[76]  M. Daly,et al.  An Atlas of Genetic Correlations across Human Diseases and Traits , 2015, Nature Genetics.

[77]  B. Klaholz,et al.  Structure and function insights into the NuRD chromatin remodeling complex , 2015, Cellular and Molecular Life Sciences.

[78]  Keith A. Johnson,et al.  Invited review: Frontotemporal dementia caused by microtubule-associated protein tau gene (MAPT) mutations: a chameleon for neuropathology and neuroimaging , 2015, Neuropathology and applied neurobiology.

[79]  S. Thompson,et al.  Multivariable Mendelian Randomization: The Use of Pleiotropic Genetic Variants to Estimate Causal Effects , 2015, American journal of epidemiology.

[80]  M. Daly,et al.  LD Score regression distinguishes confounding from polygenicity in genome-wide association studies , 2014, Nature Genetics.

[81]  Benjamin M. Neale,et al.  Genetic Consortium for Anorexia Nervosa of the Wellcome Trust Case Control Consortium , 2015 .

[82]  M. Gelb,et al.  Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. , 2014, Blood.

[83]  N. Zilka,et al.  Microglia display modest phagocytic capacity for extracellular tau oligomers , 2014, Journal of Neuroinflammation.

[84]  J. Haines,et al.  Association of MAPT haplotypes with Alzheimer’s disease risk and MAPT brain gene expression levels , 2014, Alzheimer's Research & Therapy.

[85]  Lesley M. Chapman,et al.  Emerging roles for platelets as immune and inflammatory cells. , 2014, Blood.

[86]  F. Silver,et al.  White blood cell count is an independent predictor of outcomes after acute ischaemic stroke , 2014, European journal of neurology.

[87]  Michael W. Weiner,et al.  The future of blood-based biomarkers for Alzheimer's disease , 2014, Alzheimer's & Dementia.

[88]  Lama M Chahine,et al.  Blood-based biomarkers for Parkinson's disease. , 2014, Parkinsonism & related disorders.

[89]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[90]  D. Dash,et al.  Regulation of β-catenin stabilization in human platelets. , 2013, Biochimie.

[91]  Ellen T. Gelfand,et al.  The Genotype-Tissue Expression (GTEx) project , 2013, Nature Genetics.

[92]  Kenny Q. Ye,et al.  An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.

[93]  C. Tanner,et al.  Late-life hemoglobin and the incidence of Parkinson's disease , 2012, Neurobiology of Aging.

[94]  W. Nolen,et al.  An activated set point of T-cell and monocyte inflammatory networks in recent-onset schizophrenia patients involves both pro- and anti-inflammatory forces. , 2011, The international journal of neuropsychopharmacology.

[95]  M. Huynen,et al.  A mutation in C2orf64 causes impaired cytochrome c oxidase assembly and mitochondrial cardiomyopathy. , 2011, American journal of human genetics.

[96]  X. Montalban,et al.  Tyrosine kinase 2 variant influences T lymphocyte polarization and multiple sclerosis susceptibility. , 2011, Brain : a journal of neurology.

[97]  G. Blobel,et al.  FOG1 requires NuRD to promote hematopoiesis and maintain lineage fidelity within the megakaryocytic-erythroid compartment. , 2009, Blood.

[98]  E. Hirsch,et al.  Neuroinflammation in Parkinson's disease: a target for neuroprotection? , 2009, The Lancet Neurology.

[99]  A. Eklund,et al.  GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein , 2008, Proceedings of the National Academy of Sciences.

[100]  A. Minagar,et al.  Evidence of platelet activation in multiple sclerosis , 2008, Journal of Neuroinflammation.

[101]  D. Zeng,et al.  Early-life and adult socioeconomic status and inflammatory risk markers in adulthood , 2007, European Journal of Epidemiology.

[102]  S. Deutsch,et al.  Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[103]  M. L. Pucak,et al.  The immune system and neuropsychiatric diseases , 2005, International review of psychiatry.

[104]  M. Bates,et al.  Risk factors and neuropsychological recovery in clients with alcohol use disorders who were exposed to different treatments. , 2004, Journal of consulting and clinical psychology.

[105]  G. Deuschl,et al.  Platelet–leukocyte interaction and platelet activation in migraine: a link to ischemic stroke? , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[106]  K. Chung,et al.  Evidence that alpha-synuclein functions as a negative regulator of Ca(++)-dependent alpha-granule release from human platelets. , 2002, Blood.

[107]  J. Antel,et al.  Migration of multiple sclerosis lymphocytes through brain endothelium. , 2002, Archives of neurology.

[108]  P E Shrout,et al.  Socioeconomic status and psychiatric disorders: the causation-selection issue. , 1992, Science.

[109]  A. H. V. Schapira,et al.  MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE , 1989, The Lancet.